SEC Form D · Amendment · filed September 9, 2021
Cedilla Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Dominik Naczynski · Cambridge, MADirectorEli Casdin · Cambridge, MADirectorAbbie Celniker · Cambridge, MADirectorNeil Exter · Cambridge, MADirectorAlexandra Glucksmann · Cambridge, MAExec · DirectorChris Bowden · Cambridge, MADirectorRosana Kapeller · Cambridge, MADirectorStephen Holler · Vancouver, British Columbia, CanadaDirectorAmir Achourie · Los Angeles, CAExec · DirectorJeffrey Davison · Bethlehem, PADirectorPaul Stern · Vancouver, British Columbia, CanadaDirectorPrashant Raj · Vancouver, British Columbia, CanadaDirectorMichael M. Carroll · Richmond, VADirectorYousaf Sami · Vancouver, British Columbia, CanadaDirectorRoann Costin · NEW YORK, NYDirectorAlex Madkour · Seattle, WADirectorEM Alpine Holdings, LLC · New York, NYDirectorDaniel M. Labovitz · Gladstone, NJDirectorRobert R. Wotzcak · Gladstone, NJDirectorCharles R. Dolan · Gladstone, NJExec · DirectorAlexander R. Kontoleon · Gladstone, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗